Artigo Acesso aberto Revisado por pares

Animal Models are Essential to Biological Research: Issues and Perspectives

2015; Future Science Ltd; Volume: 1; Issue: 4 Linguagem: Inglês

10.4155/fso.15.63

ISSN

2056-5623

Autores

Françoise Barré‐Sinoussi, Xavier Montagutelli,

Tópico(s)

Aquaculture disease management and microbiota

Resumo

Future Science OAVol. 1, No. 4 OpinionOpen AccessAnimal models are essential to biological research: issues and perspectivesFrançoise Barré-Sinoussi & Xavier MontagutelliFrançoise Barré-Sinoussi INSERM & Unité de Régulation des Infections Rétrovirales, Institut Pasteur, 75724 Paris, FranceSearch for more papers by this author & Xavier Montagutelli*Author for correspondence: E-mail Address: xavier.montagutelli@pasteur.fr Animalerie Centrale, Institut Pasteur, 75724 Paris, FranceSearch for more papers by this authorPublished Online:31 Jul 2015https://doi.org/10.4155/fso.15.63AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInReddit Keywords: animal modelsanimal protectionanimal researchanimal welfarehuman diseasespreclinical studiesThe use of animals for scientific purposes is both a longstanding practice in biological research and medicine, and a frequent matter of debate in our societies. The remarkable anatomical and physiological similarities between humans and animals, particularly mammals, have prompted researchers to investigate a large range of mechanisms and assess novel therapies in animal models before applying their discoveries to humans. However, not all results obtained on animals can be directly translated to humans, and this observation is emphasized by those who refute any value to animal research. At the same time, the place of the animals in our modern societies is often debated, particularly the right to use animals to benefit human purposes, with the possibility that animals are harmed. These two aspects are often mixed in confusing arguments, which does not help citizens and politicians to get a clear picture of the issues. This has been the case in particular during the evaluation of the European Citizen Initiative (ECI) ‘Stop Vivisection’ recently presented to the European Commission [1].Humans and other mammals are very complex organisms in which organs achieve distinct physiological functions in a highly integrated and regulated fashion. Relationships involve a complex network of hormones, circulating factors and cells and cross-talk between cells in all the compartments. Biologists interrogate organisms at multiple levels: molecules, cells, organs and physiological functions, in healthy or diseased conditions. All levels of investigations are required to get a full description and understanding of the mechanisms. The first two, and in some instances three, levels of organization can be studied using in vitro approaches (e.g., cell culture). These techniques have become very sophisticated to mimic the 3D and complex structures of tissues. They represent major scientific advances and they have replaced the use of animals. On the other hand, the exploration of physiological functions and systemic interactions between organs requires a whole organism. It is, for example, the case for most hormonal regulations, for the dissemination of microorganisms during infectious diseases or for the influence of the intestinal microorganisms on immune defense or on the development of brain functions. In these many cases, no in vitro model is currently available to fully recapitulate these interactions, and investigations on humans and animals are still necessary. Hypotheses and models can emerge from in vitro studies but they must be tested and validated in a whole organism, otherwise they remain speculative. Scientists are very far from being able to predict the functioning of a complex organism from the study of separate cells, tissues and organs. Therefore, despite arguments put forward by the promotors of the ECI, studies on animals cannot be fully replaced by in vitro methods, and it is still a long way before they can.Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans. A number of major breakthroughs in basic science and medical research have been possible because of observations and testing on animal models. Most vaccines, which save millions of human and animal lives every year, have been successfully developed using animal models. The treatment of Type I diabetes by insulin was first established in the dog by Banting and McLeod who received the Nobel Prize in 1921 [2]. Cellular therapies for tissue regeneration using stem cells have been engineered and tested in animals [3]. Many surgical techniques have been designed and improved in various animal species before being applied to humans. The discoveries in which animal models played a critical role are indeed numerous and led to many Nobel Prizes.It is, however, noticeable that the results obtained on animals are not necessarily confirmed in further human studies. Various reasons can be evoked. First, despite large similarities, there are differences between a given animal species and humans. For example, over 95% of the genes are homologous between mice and humans but there are also differences for example in the members of genes families, in gene redundancies and in the fine regulation of gene-expression level. These genetic differences translate into physiological differences which are increasingly better described and understood. While some people like the ECI promotors use these differences to refute the value of animal models, many including ourselves strongly advocate for further improving our knowledge and understanding of these differences and for taking them into account in experimental designs and interpretation of observations [4]. Moreover, these differences may provide opportunities to unravel novel mechanisms and imagine innovative therapies.The second reason is due to genetic and physiological variations within each species or between closely related species. Laboratory mice have been developed as inbred strains which have highly homogeneous genetic composition to increase the reproducibility of results and the statistical power of experiments. Reports on animal models of human conditions often speak of ‘the mouse model of…’, referring in fact to observations made in a given genetic background. However, the clinical presentation often varies if another mouse strain is considered. A striking example is provided by a study published in November 2014 in Science by a team who reported that some mouse strains are fully resistant to Ebola virus, others die without specific symptoms and others develop fatal hemorrhagic fever [5]. Another example is the difference of responses to SIV, the monkey homolog to human HIV, between Rhesus macaques which develop simian AIDS and sooty mangabeys which do not develop symptoms despite high levels of circulating virus [6]. This range of responses reflects in fact the variety of clinical observations among human patients. These examples illustrate how animal models must be considered: no single animal model is able to mimic a given human disease which is itself polymorphic between patients, but the differences between strains or species provide unmatched opportunity to understand disease development and differential host response, and to eventually find new cures.The second issue regarding the use of animals for scientific purposes is animal protection and welfare. This is the scope of the European Directive 2010/63/EU, which has set the regulatory framework for all animal research. Scientists have recognized for decades the importance of giving full consideration to three fundamental principles [7], which have become the backbone of the European Directive. First, animals must not be used whenever other, non-animal-based, experimental approaches are available, with similar relevance and reliability. Second, the number of animals used must be adjusted to the minimum needed to reach a conclusion. Third, all provisions must be taken throughout the procedures to minimize any harm inflicted to the animals. These principles, known as ‘the three Rs rules’, for replacement, reduction and refinement, have become the standard to which every project involving the use of animals is evaluated.Animal research is conducted in compliance with regulatory provisions which cover the inspection and licensing of animal premises, the training and competence of all personal designing projects, performing animal procedures and taking care of animals and the mandatory authorization of every project by a competent authority upon ethical evaluation by an Animal Ethics Committee. The criteria for evaluation are based on the 3Rs rules and a cost–benefit analysis to evaluate if the potential harm to the animals, which must be reduced to the lowest possible level, is outweighed by significant progress in terms of knowledge on human or animal health. Regulation imposes that ethics committees include members concerned by animal protection and not involved in animal research. In response to the ECI, the European Commission has underlined, in a statement issued on 3 June 2015 [8], that animal experimentation remains important for improving human and animal health. At the same time, it is committed to promoting the development and validation of non-animal-based approaches, and to enforcing the application of the 3Rs rules by all players, including the research community. Europe has therefore implemented one of the strictest regulatory frameworks for the protection of animals used in research.The greatest challenges faced by modern biomedical research concern complex, multifactorial, diseases such as cancer, cardiovascular diseases, infectious diseases, neurodegenerative disorders, pathological consequences of aging among others, for which all experimental approaches are indispensable because of their complementarity: biochemistry, genomics, cell culture, computer modeling, animal model and clinical studies. Research on relevant, carefully designed, well-characterized and controlled animal models will remain for a long time an essential step for fundamental discoveries, for testing hypotheses at the organism level and for the validation of human data. Animal models must be constantly improved to be more reliable and informative. Likewise, animal protection requires permanent consideration. These two objectives, far from being antagonistic, must be anchored in high-quality science.Financial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.Open AccessThis work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/References1 The European Citizens ‘Initiative – Stop vivisection. http://ec.europa.euGoogle Scholar2 Nobelprize.Org – The discovery of insulin. www.nobelprize.orgGoogle Scholar3 Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 98(1), 216–224 (1996).Crossref, Medline, CAS, Google Scholar4 Ergorul C, Levin LA. An example on glaucoma research: solving the lost in translation problem: improving the effectiveness of translational research. Curr. Opin. Pharmacol. 13(1), 108–114 (2013).Crossref, Medline, CAS, Google Scholar5 Rasmussen AL, Okumura A, Ferris MT et al. Host genetic diversity enables ebola hemorrhagic fever pathogenesis and resistance. Science 346(6212), 987–991 (2014).Crossref, Medline, CAS, Google Scholar6 Liovat AS, Jacquelin B, Ploquin MJ, Barre-Sinoussi F, Muller-Trutwin MC. African non human primates infected by SIV – why don’t they get sick? Lessons from studies on the early phase of non-pathogenic siv infection. Curr. HIV Res. 7(1), 39–50 (2009).Crossref, Medline, CAS, Google Scholar7 Russell WMS, Burch RL. The Principles of Human Experimental Technique. Methuen, London, UK (1959).Google Scholar8 European Commission – Annex to the communication from the commission on the European Citizen's Initiative, ‘Stop Vivisection’. http://ec.europa.eu Google ScholarFiguresReferencesRelatedDetailsCited ByRobustness of a multivariate composite score when evaluating distress of animal models for gastrointestinal diseases14 February 2023 | Scientific Reports, Vol. 13, No. 1Preclinical evaluation of molecularly targeted fluorescent probes in perfused amputated human limbsJournal of Biomedical Optics, Vol. 28, No. 08An Overview of Biotechnological Applications in Ayurveda: Amalgamation of Modern Techniques and ScienceCurrent Traditional Medicine, Vol. 9, No. 1Analysis of metabolites and metabolism-mediated biological activity assessment of ginsenosides on microfluidic co-culture system30 January 2023 | Frontiers in Pharmacology, Vol. 14Negotiating the necessity of biomedical animal use through relations with vulnerability7 January 2023 | BioSocieties, Vol. 20Role of neurogenesis in regenerative medicineMulti-species welfare issuesMicrofluidic trends in drug screening and drug deliveryTrAC Trends in Analytical Chemistry, Vol. 158Biosensors for organs-on-a-chip and organoidsBridging the gap between preclinical scientists, clinical researchers, and clinicians: From animal research to clinical practice12 January 2023 | Headache: The Journal of Head and Face Pain, Vol. 63, No. 1Experimental Model for Pancreatic Cancer and Its Therapeutic Implications in Clinical Research1 February 2023Mouse as a Preclinical Model for Studying Small Noncoding RNAs Involved in Colorectal Cancer1 February 2023The Indispensable Contribution of Nonhuman Primates to Biomedical Research2 February 2023An Unexpected Symbiosis of Animal Welfare and Clinical Relevance in a Refined Nonhuman Primate Model of Human Autoimmune Disease2 February 2023Recent advances in genetically modified large-animal models of human diseasesBIO Integration, Vol. 3, No. 4Role of animal models in biomedical research: a review1 July 2022 | Laboratory Animal Research, Vol. 38, No. 1Modelling urea cycle disorders using iPSCs26 September 2022 | npj Regenerative Medicine, Vol. 7, No. 1Paternal age impairs in vitro embryo and in vivo fetal development in murine29 July 2022 | Scientific Reports, Vol. 12, No. 1It Is Premature to Use Postmortem Sperm for Reproductive Purposes: a Data-Driven Opinion10 February 2022 | Reproductive Sciences, Vol. 29, No. 12Animal Models of Rotator Cuff Injury and Repair: A Systematic ReviewTissue Engineering Part B: Reviews, Vol. 28, No. 6Artificial intelligence in veterinary care will be a major driving force behind AI advancements in healthcare13 December 2022 | Veterinary Radiology & Ultrasound, Vol. 63, No. S1Metabolome Profiling in Aging Studies26 October 2022 | Biology, Vol. 11, No. 11Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic SteatohepatitisJournal of Clinical and Experimental Hepatology, Vol. 12, No. 6Metabolome profiling in the study of aging processes1 January 2022 | Biomeditsinskaya Khimiya, Vol. 68, No. 5Poor Reporting Quality in Basic Nutrition Research: A Case Study Based on a Scoping Review of Recent Folate Research in Mouse Models (2009–2021)Advances in Nutrition, Vol. 13, No. 6Cardiac tissue engineering: Multiple approaches and potential applications3 October 2022 | Frontiers in Bioengineering and Biotechnology, Vol. 10Smart and Multi-Functional Magnetic Nanoparticles for Cancer Treatment Applications: Clinical Challenges and Future Prospects12 October 2022 | Nanomaterials, Vol. 12, No. 20How Does Botulinum Toxin Inhibit Itch?12 October 2022 | Toxins, Vol. 14, No. 10Lung Organoids in Smoking Research: Current Advances and Future Promises12 October 2022 | Biomolecules, Vol. 12, No. 10Bioinspired Silk Fibroin Mineralization for Advanced In Vitro Bone Remodeling Models7 August 2022 | Advanced Functional Materials, Vol. 32, No. 41A Systematic Review of the Potential Effects of Propolis Extracts on Experimentally-induced Diabetes28 September 2022 | Planta Medica, Vol. 6A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder5 September 2022 | Experimental Brain Research, Vol. 51Transgenic Rodent Models in Toxicological and Environmental Research: Future Perspectives28 November 2022 | Journal of Pharmacology and Pharmacotherapeutics, Vol. 13, No. 3Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development10 August 2022 | Frontiers in Microbiology, Vol. 13Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model2 August 2022 | Frontiers in Immunology, Vol. 13Pharmacological evaluation of Thuja occidentalis for the attenuation of neuropathy via AGEs and TNF-α inhibition in diabetic neuropathic rats14 April 2022 | Environmental Science and Pollution Research, Vol. 29, No. 40Murine models of radiation cardiotoxicity: A systematic review and recommendations for future studiesRadiotherapy and Oncology, Vol. 173A Complete Review of Mexican Plants with Teratogenic Effects24 June 2022 | Plants, Vol. 11, No. 13Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro18 July 2022 | Pharmaceuticals, Vol. 15, No. 7Acrolein, an environmental toxicant and its applications to in vivo and in vitro atherosclerosis models: An updateEnvironmental Toxicology and Pharmacology, Vol. 93Human Platelet Lysate as Alternative of Fetal Bovine Serum for Enhanced Human In Vitro Bone Resorption and Remodeling20 June 2022 | Frontiers in Immunology, Vol. 13Murine Models of Obesity31 March 2022 | Obesities, Vol. 2, No. 2CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease13 June 2022 | Pharmaceutics, Vol. 14, No. 6Quantitative biophysical metrics for rapid evaluation of ovarian cancer metastatic potentialMolecular Biology of the Cell, Vol. 33, No. 6Barrier materials for prevention of surgical adhesions: systematic review6 June 2022 | BJS Open, Vol. 6, No. 3An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy8 May 2022 | Cells, Vol. 11, No. 9Group B Streptococcal Neonatal MeningitisClinical Microbiology Reviews, Vol. 35, No. 2Evaluation of patches for rotator cuff repair: A systematic review and meta-analysis based on animal studiesBioactive Materials, Vol. 10Structured Long-Chain Omega-3 Fatty Acids for Improvement of Cognitive Function during Aging23 March 2022 | International Journal of Molecular Sciences, Vol. 23, No. 7Identification and coregulation pattern analysis of long noncoding RNAs following subacute spinal cord injury6 June 2021 | Journal of Orthopaedic Research, Vol. 40, No. 3Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species30 December 2021 | Drug Metabolism and Disposition, Vol. 50, No. 3Generation of Alveolar Epithelium Using Reconstituted Basement Membrane and hiPSC‐Derived Organoids7 January 2022 | Advanced Healthcare Materials, Vol. 11, No. 6Mitochondrial Protein Homeostasis and Cardiomyopathy20 March 2022 | International Journal of Molecular Sciences, Vol. 23, No. 6Neural Organoids, a Versatile Model for NeuroscienceMolecules and Cells, Vol. 45, No. 2The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development21 January 2022 | Pharmaceutics, Vol. 14, No. 2Excitability properties of mouse and human skeletal muscle fibres compared by muscle velocity recovery cyclesNeuromuscular Disorders, Vol. 1Patch-based 3D U-Net and transfer learning for longitudinal piglet brain segmentation on MRIComputer Methods and Programs in Biomedicine, Vol. 2143D culture platform of human iPSCs-derived nociceptors for peripheral nerve modeling and tissue innervation30 November 2021 | Biofabrication, Vol. 14, No. 1Animal models of inflammatory musculoskeletal diseases for tissue engineering and regenerative medicine: updates and translational applicationEffect of a Sub-Chronic Oral Exposure of Broccoli (Brassica oleracea L. Var. Italica) By-Products Flour on the Physiological Parameters of FVB/N Mice: A Pilot Study4 January 2022 | Foods, Vol. 11, No. 1Microbial Translocation and Perinatal Asphyxia/Hypoxia: A Systematic Review16 January 2022 | Diagnostics, Vol. 12, No. 1Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models21 December 2021 | Micromachines, Vol. 13, No. 1Organ-on-chip for assessing environmental toxicantsMechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques1 June 2022 | Journal of Inflammation Research, Vol. Volume 15Drill-Hole Bone Defects in Animal Models of Bone Healing: Protocol for a Systematic Review18 July 2022 | JMIR Research Protocols, Vol. 11, No. 7Animal Tests to Determine the Health Risks of Indoor Air Pollutants29 July 2022Experimental Model for Pancreatic Cancer and Its Therapeutic Implications in Clinical Research6 October 2022Stem Cells: Use in Nephrology29 October 2022What Can We Learn from Animal Models to Study Schizophrenia?6 August 2022Mouse as a Preclinical Model for Studying Small Noncoding RNAs Involved in Colorectal Cancer19 August 2022Animal and computational models in toxicology and pharmacologyAnimal Tests to Determine the Health Risks of Indoor Air Pollutants24 November 2022Alternative animal models in predictive toxicologyToxicology, Vol. 465The modulatory effect of crotoxin and its phospholipase A2 subunit from Crotalus durissus terrificus venom on dendritic cells interferes with the generation of effector CD4+ T lymphocytesImmunology Letters, Vol. 240Animal Models in Human Adenovirus Research1 December 2021 | Biology, Vol. 10, No. 12MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease?30 November 2021 | Cells, Vol. 10, No. 12Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation14 December 2021 | Pharmaceuticals, Vol. 14, No. 12Evaluation of Tissue Engineering Approaches for Intervertebral Disc Regeneration in Relevant Animal Models15 October 2021 | ACS Applied Bio Materials, Vol. 4, No. 11Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage13 November 2021 | Cells, Vol. 10, No. 11Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement15 September 2021 | ACS Applied Bio Materials, Vol. 4, No. 10Testicular Histopathology and Spermatogenesis in Mice with Scrotal Heat Stress15 October 2021Establishment of a Pre-vascularized 3D Lung Cancer Model in Fibrin Gel—Influence of Hypoxia and Cancer-Specific Therapeutics14 October 2021 | Frontiers in Bioengineering and Biotechnology, Vol. 9Scientific inertia in animal-based research in biomedicineStudies in History and Philosophy of Science Part A, Vol. 89A network analysis of angiogenesis/osteogenesis-related growth factors in bone tissue engineering based on in-vitro and in-vivo data: A systems biology approachTissue and Cell, Vol. 72Interests of the Non-Human Primate Models for HIV Cure Research27 August 2021 | Vaccines, Vol. 9, No. 9A review of animal models from 2015 to 2020 for preclinical chronic wounds relevant to human healthJournal of Tissue Viability, Vol. 30, No. 3The Impact of Physical Exercise on the Circulating Levels of BDNF and NT 4/5: A Review16 August 2021 | International Journal of Molecular Sciences, Vol. 22, No. 16Peripheral neurovascular link: an overview of interactions and in vitro modelsTrends in Endocrinology & Metabolism, Vol. 32, No. 8Combined Treatment of Photobiomodulation and Arginine on Chronic Wound Healing in an Animal Model24 July 2021 | Journal of Lasers in Medical Sciences, Vol. 12, No. 1Prospect of in vitro Bile Fluids Collection in Improving Cell-Based Assay of Liver Function3 June 2021 | Frontiers in Toxicology, Vol. 3Murine models for heart failure: Their creation and applicability to human still require critical and careful considerationsIJC Heart & Vasculature, Vol. 34Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies25 April 2021 | European Journal of Neuroscience, Vol. 53, No. 11Predictive Markers of Immunogenicity and Efficacy for Human Vaccines1 June 2021 | Vaccines, Vol. 9, No. 6Effect of a bovine collagen matrix on tendon adhesions during the repair of rat Achilles tendonHand Surgery and Rehabilitation, Vol. 40, No. 3Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine28 November 2020 | Pain and Therapy, Vol. 10, No. 1Adipose-Derived Stromal/Stem Cells from Large Animal Models: from Basic to Applied Science6 October 2020 | Stem Cell Reviews and Reports, Vol. 17, No. 3Challenge of diabetes mellitus and researchers’ contributions to its control26 May 2021 | Open Chemistry, Vol. 19, No. 1Endothelial dysfunction and transcriptome aberration in mouse aortas induced by black phosphorus quantum dots and nanosheets1 January 2021 | Nanoscale, Vol. 13, No. 19Mimicking biofilm formation and development: Recent progress in in vitro and in vivo biofilm modelsiScience, Vol. 24, No. 5The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment15 April 2021 | Frontiers in Genetics, Vol. 12Intensive longitudinal characterization of multidimensional biobehavioral dynamics in laboratory ratsCell Reports, Vol. 35, No. 2Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysisAnalytica Chimica Acta, Vol. 1152Modeling Distal Convoluted Tubule (Patho)Physiology: An Overview of Past Developments and an Outlook Toward the FutureTissue Engineering Part C: Methods, Vol. 27, No. 3Legal Frameworks and Controls for the Protection of Research Animals: A Focus on the Animal Welfare Body with a French Case Study5 March 2021 | Animals, Vol. 11, No. 3Establishment of a Nanopatterned Renal Disease Model by Mimicking the Physical and Chemical Cues of a Diseased Mesangial Cell Microenvironment4 February 2021 | ACS Applied Bio Materials, Vol. 4, No. 2Myocardial Disease and Long-Distance Space Travel: Solving the Radiation Problem12 February 2021 | Frontiers in Cardiovascular Medicine, Vol. 8Human reconstructed kidney models16 February 2021 | In Vitro Cellular & Developmental Biology - Animal, Vol. 57, No. 2Infant Rabbit Model for Studying Shiga Toxin-Producing Escherichia coli12 March 2021Preclinical Models for Wound-Healing and Repair Studies21 July 2021Translational Models for ENDP AssessmentMesoporous silica nanoparticles for drug combination delivery in cancer therapyLab Animal Models and Analogies with Humans2 November 2021Application of Biomedical Molecular Techniques in Environmental Sciences2 August 2021Animal Models in Pharmacology: A Brief History Awarding the Nobel Prizes for Physiology or Medicine21 May 2021 | Pharmacology, Vol. 106, No. 7-8Generation of Cortical, Dopaminergic, Motor, and Sensory Neurons from Human Pluripotent Stem Cells7 May 2021Safe-in-Man Broad Spectrum Antiviral Agents14 July 2021Experimental Wound-Care Models: In Vitro/In Vivo Models and Recent Advances Based on Skin-on-a-Chip Models21 July 2021In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis2 December 2020 | PLOS ONE, Vol. 15, No. 12Integrating Philosophy of Science into Research on Ethical, Legal and Social Issues in the Life SciencesPerspectives on Science, Vol. 28, No. 6Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence14 July 2020 | The Journal of Headache and Pain, Vol. 21, No. 1Animal models of disuse-induced bone loss: study protocol for a systematic review16 August 2020 | Systematic Reviews, Vol. 9, No. 1Classic and evolving animal models in Parkinson's diseasePharmacology Biochemistry and Behavior, Vol. 199Sex-specific associations between co-exposure to multiple metals and visuospatial learning in early adolescence21 October 2020 | Translational Psychiatry, Vol. 10, No. 13D-bioprinted all-inclusive bioanalytical platforms for cell studies4 September 2020 | Scientific Reports, Vol. 10, No. 1Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle29 October 2020 | Scientific Reports, Vol. 10, No. 1Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex12 November 2020 | Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 376Estimated 24-hour urinary sodium excretion as a risk factor for oxidative stress in Zambian adults: A cross-sectional study12 November 2020 | PLOS ONE, Vol. 15, No. 11Radiation induced cardiovascular disease: An odyssey of bedside-bench-bedside approachLife Sciences in Space Research, Vol. 27Fluorescent PSC-Derived Cardiomyocyte Reporter Lines: Generation Approaches and Their Applications in Cardiovascular Medicine16 November 2020 | Biology, Vol. 9, No. 11Impetigo Animal Models: A Re

Referência(s)